Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cost Of Revenue | 55,062 | 0.00 | -- | -- | -- |
| Gross Profit | -55,062 | 0.00 | -- | -- | -- |
| Selling General And Administration | 4.0M | 3.1M | 3.9M | 3.9M | -- |
| General And Administrative Expense | 3.8M | 2.1M | 2.6M | 2.8M | -- |
| Other Operating Expenses | 112,076 | 129,141 | 134,875 | 127,535 | -- |
| Operating Expense | 4.1M | 3.3M | 4.0M | 4.0M | -- |
| Operating Income | -4.2M | -3.3M | -4.0M | -4.0M | -- |
| EBIT | -5.2M | -2.8M | -4.0M | -4.0M | -- |
| Interest Expense | 605,025 | 0.00 | -- | -- | -- |
| Interest Expense Non Operating | 605,025 | 0.00 | -- | -- | -- |
| Interest Income | 1,135 | 116,644 | 0.00 | -- | -- |
| Interest Income Non Operating | 1,135 | 116,644 | 0.00 | -- | -- |
| Net Interest Income | -638,792 | 116,644 | 0.00 | -- | -- |
| Other Income Expense | -956,637 | 373,823 | 1.3M | 228,400 | -- |
| Other Non Operating Income Expenses | -- | 373,823 | 1.3M | 228,400 | 42,087 |
| Gain On Sale Of Security | -956,637 | -- | -- | -- | -- |
| Pretax Income | -5.8M | -2.8M | -2.7M | -3.8M | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -5.8M | -2.8M | -2.7M | -3.8M | -- |
| Net Income From Continuing Operation Net Minority Interest | -5.8M | -2.8M | -2.7M | -3.8M | -- |
| Net Income Including Noncontrolling Interests | -5.8M | -2.8M | -2.7M | -3.8M | -- |
| Net Income Common Stockholders | -5.8M | -2.8M | -2.7M | -3.8M | -- |
| Net Income | -5.8M | -2.8M | -2.7M | -3.8M | -- |
| EBITDA | -5.1M | -2.8M | -4.0M | -4.0M | -- |
| Normalized EBITDA | -4.1M | -2.8M | -4.0M | -4.0M | -- |
| Reconciled Depreciation | 55,062 | 0.00 | -- | -- | -- |
| Basic EPS | -0.02 | -0.01 | -0.02 | -0.04 | -- |
| Diluted EPS | -0.02 | -0.01 | -0.02 | -0.04 | -- |
| Basic Average Shares | 259.6M | 249.1M | 178.5M | 95.9M | -- |
| Diluted Average Shares | 259.6M | 249.1M | 178.5M | 95.9M | -- |
| Total Unusual Items | -956,637 | -- | -- | -- | -- |
| Total Unusual Items Excluding Goodwill | -956,637 | -- | -- | -- | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -4.8M | -2.8M | -2.7M | -3.8M | -- |
| Diluted NI Availto Com Stockholders | -5.8M | -2.8M | -2.7M | -3.8M | -- |
| Net Income Continuous Operations | -5.8M | -2.8M | -2.7M | -3.8M | -- |
| Net Non Operating Interest Income Expense | -638,792 | 116,644 | 0.00 | -- | -- |
| Other Gand A | 2.7M | 1.4M | 1.6M | 1.2M | -- |
| Reconciled Cost Of Revenue | 55,062 | 0.00 | -- | -- | -- |
| Salaries And Wages | 1.1M | 631,632 | 997,977 | 1.5M | -- |
| Selling And Marketing Expense | 210,184 | 1.1M | 1.3M | 1.1M | -- |
| Total Expenses | 4.2M | 3.3M | 4.0M | 4.0M | -- |
| Total Other Finance Cost | 34,902 | -- | -- | -- | -- |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 695,260 | 916,066 | 1.8M | 724,812 | -- |
| Cash Cash Equivalents And Short Term Investments | 695,260 | 916,066 | 1.8M | 724,812 | -- |
| Cash Financial | 695,260 | 916,066 | 1.8M | 724,812 | -- |
| Receivables | 131,735 | 125,697 | 189,816 | 206,784 | -- |
| Prepaid Assets | 54,831 | 129,978 | 94,178 | 45,133 | -- |
| Current Assets | 881,826 | 1.2M | 2.0M | 976,729 | -- |
| Gross PPE | 44.7M | 40.8M | -- | -- | -- |
| Net PPE | 44.7M | 40.8M | 30.3M | 24.1M | -- |
| Total Non Current Assets | 44.8M | 41.5M | 30.7M | 24.3M | -- |
| Total Assets | 45.7M | 42.6M | 32.7M | 25.3M | -- |
| Current Debt | 3.4M | -- | -- | -- | -- |
| Current Debt And Capital Lease Obligation | 3.5M | -- | -- | -- | -- |
| Accounts Payable | 2.3M | 793,913 | -- | -- | -- |
| Payables | 3.0M | 808,911 | -- | -- | -- |
| Payables And Accrued Expenses | 3.1M | 808,911 | 282,698 | 668,616 | -- |
| Current Accrued Expenses | 98,630 | 0.00 | -- | -- | -- |
| Other Current Liabilities | 1.8M | -- | 373,823 | -- | 228,400 |
| Current Liabilities | 8.4M | 808,911 | 656,521 | 668,616 | -- |
| Long Term Debt And Capital Lease Obligation | 5,909 | -- | -- | -- | -- |
| Long Term Capital Lease Obligation | 5,909 | -- | -- | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 5,909 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 8.4M | 808,911 | 656,521 | 668,616 | -- |
| Common Stock | 51.9M | 51.6M | 40.0M | 30.3M | -- |
| Capital Stock | 51.9M | 51.6M | 40.0M | 30.3M | -- |
| Retained Earnings | -21.2M | -15.4M | -12.6M | -9.9M | -- |
| Gains Losses Not Affecting Retained Earnings | 6.6M | 5.6M | 4.8M | 3.6M | -- |
| Common Stock Equity | 37.3M | 41.8M | 32.1M | 24.6M | -- |
| Stockholders Equity | 37.3M | 41.8M | 32.1M | 24.6M | -- |
| Total Equity Gross Minority Interest | 37.3M | 41.8M | 32.1M | 24.6M | -- |
| Total Capitalization | 37.3M | 41.8M | 32.1M | 24.6M | -- |
| Net Tangible Assets | 37.3M | 41.8M | 32.1M | 24.6M | -- |
| Tangible Book Value | 37.3M | 41.8M | 32.1M | 24.6M | -- |
| Working Capital | -7.5M | 362,830 | 1.4M | 308,113 | -- |
| Invested Capital | 40.7M | 41.8M | 32.1M | 24.6M | -- |
| Total Debt | 3.5M | 0.00 | -- | -- | -- |
| Net Debt | 2.8M | -- | -- | -- | -- |
| Share Issued | 260.7M | 258.6M | 207.7M | 161.3M | -- |
| Ordinary Shares Number | 260.7M | 258.6M | 207.7M | 161.3M | -- |
| Buildings And Improvements | 65,074 | 0.00 | -- | -- | -- |
| Capital Lease Obligations | 70,362 | 0.00 | -- | -- | -- |
| Current Capital Lease Obligation | 64,453 | 0.00 | -- | -- | -- |
| Dueto Related Parties Current | 705,812 | 14,998 | -- | -- | -- |
| Interest Payable | 98,630 | 0.00 | -- | -- | -- |
| Non Current Prepaid Assets | 72,450 | 666,369 | 417,630 | 146,186 | -- |
| Other Current Borrowings | 3.4M | -- | -- | -- | -- |
| Other Equity Interest | -- | -- | -- | 626,610 | -- |
| Other Properties | 44.7M | 40.8M | -- | -- | -- |
| Taxes Receivable | 131,735 | 125,697 | 189,816 | 206,784 | -- |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -2.5M | -2.6M | -3.0M | -2.4M | -- |
| Cash Flow From Continuing Operating Activities | -2.5M | -2.6M | -3.0M | -2.4M | -- |
| Depreciation And Amortization | 55,062 | 0.00 | -- | -- | -- |
| Depreciation Amortization Depletion | 55,062 | 0.00 | -- | -- | -- |
| Stock Based Compensation | 959,976 | 631,632 | 997,977 | 1.5M | -- |
| Deferred Tax | -- | -- | -- | -228,400 | -42,087 |
| Deferred Income Tax | -- | -- | -- | -228,400 | -42,087 |
| Change In Working Capital | 488,982 | -101,536 | 74,315 | 115,434 | -- |
| Change In Receivables | -6,038 | 64,119 | 16,968 | 32,447 | -- |
| Change In Payables And Accrued Expense | 419,873 | -129,855 | 106,392 | 96,520 | -- |
| Other Non Cash Items | 781,025 | -373,823 | -1.3M | -228,400 | -- |
| Capital Expenditure | -1.5M | -10.1M | -6.9M | -2.9M | -- |
| Purchase Of PPE | -1.5M | -10.1M | -6.9M | -2.9M | -- |
| Net PPE Purchase And Sale | -1.5M | -10.1M | -6.9M | -2.9M | -- |
| Investing Cash Flow | -1.5M | -10.1M | -6.9M | -3.0M | -- |
| Cash Flow From Continuing Investing Activities | -1.5M | -10.1M | -6.9M | -3.0M | -- |
| Issuance Of Debt | 4.0M | 0.00 | -- | -- | -- |
| Repayment Of Debt | -180,858 | 0.00 | -- | -- | -- |
| Net Issuance Payments Of Debt | 3.8M | 0.00 | -- | -- | -- |
| Issuance Of Capital Stock | 0.00 | 13.2M | 11.5M | 5.6M | -- |
| Net Common Stock Issuance | 0.00 | 13.2M | 11.5M | 5.6M | -- |
| Financing Cash Flow | 3.8M | 11.9M | 10.9M | 5.2M | -- |
| Cash Flow From Continuing Financing Activities | 3.8M | 11.9M | 10.9M | 5.2M | -- |
| Changes In Cash | -220,806 | -846,490 | 1.0M | -124,654 | -- |
| Beginning Cash Position | 916,066 | 1.8M | 724,812 | 849,466 | -- |
| End Cash Position | 695,260 | 916,066 | 1.8M | 724,812 | -- |
| Free Cash Flow | -4.0M | -12.7M | -9.9M | -5.2M | -- |
| Change In Prepaid Assets | 75,147 | -35,800 | -49,045 | -13,533 | -- |
| Common Stock Issuance | 0.00 | 13.2M | 11.5M | 5.6M | -- |
| Depreciation | 55,062 | 0.00 | -- | -- | -- |
| Gain Loss On Investment Securities | 956,637 | -- | -- | -- | -- |
| Long Term Debt Issuance | 4.0M | 0.00 | -- | -- | -- |
| Long Term Debt Payments | -180,858 | 0.00 | -- | -- | -- |
| Net Income From Continuing Operations | -5.8M | -2.8M | -2.7M | -3.8M | -- |
| Net Long Term Debt Issuance | 3.8M | 0.00 | -- | -- | -- |
| Net Other Financing Charges | -- | -1.4M | -953,753 | -805,135 | -194,088 |
| Net Other Investing Changes | -- | -- | -271,444 | -66,186 | -80,000 |
| Operating Gains Losses | 956,637 | -- | -- | -- | -- |
| Proceeds From Stock Option Exercised | -- | 0.00 | 333,490 | 359,500 | 1.7M |
| Sale Of PPE | -- | -- | 0.00 | 41.00 | 0.00 |